HealthDay News — Early-onset neonatal sepsis and meningitis are associated with an increased risk for childhood epilepsy, according to a study published online July 7 in JAMA Network Open.

A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging improves the accuracy of Meniere disease diagnosis.

Bedtime dosing with antihypertensive medication yields better nocturnal blood pressure control and improved circadian rhythm.

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.

The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Nightly sleep duration greater than 9.9 hours in the first week postconcussion is associated with higher symptom burden among adolescents.

Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.

HealthDay News — Racial/ethnic and socioeconomic disparities contribute to frequent emergency department visits for seizures, according to a study published online July 5 in Epilepsia.

Following priority review, the FDA approved Kerendia for the treatment of patients with heart failure with left ventricular ejection fraction (LVEF) ≥40%.

New actigraphy-based algorithm shows TAK-861 significantly increases nap free days and reduces sleep time per day among those with narcolepsy type 1.

Pediatric neurology patients who receive an outpatient follow-up appointment at the time of hospital discharge are less likely to be readmitted to the hospital within 30 days.

Long term use of once-nightly sodium oxybate is well-tolerated among patients with narcolepsy type 1 or 2 with primarily mild adverse reactions.